Vanda Pharmaceuticals Competitors and Similar CompaniesClear all
Vanda Pharmaceuticals's competitors and similar companies include Supernus Pharmaceuticals, Assembly Biosciences, Corcept Therapeutics and Inotiv.
 Vanda Pharmaceuticals Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Assembly Biosciences Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics. |  Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators. |  Inotiv Inotiv (formerly known as BioAnalytical Systems) is a company that provides research services to pharmaceutical and biotechnology companies. | |
Founding Date | Founding Date 2002 | Founding Date 2005 | Founding Date 2005 | Founding Date 1998 | Founding Date 1974 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Washington, US HQ Berlin, DE London, GB | Locations Rockville, US HQ | Locations South San Francisco, US HQ | Locations Redwood City, US HQ | Locations West Lafayette, US HQ |
Employees | Employees 2845% increase | Employees 6527% increase | Employees 11521% increase | Employees 50042% increase | Employees 1,945 |
Valuation ($) | Valuation ($) 273.4 m | Valuation ($) 1.9 b | Valuation ($) 112.4 m | Valuation ($) 5 b | Valuation ($) 47.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $216.1m (FY, 2025) | Revenue (est.) $719m (FY, 2025) | Revenue (est.) $72.3m (FY, 2025) | Revenue (est.) $761.4m (FY, 2025) | Revenue (est.) $513m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $74.6m (FY, 2025) | Cost of goods N/A | Cost of goods $13m (FY, 2025) | Cost of goods $392m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $644.4m (FY, 2025) | Gross profit N/A | Gross profit $748.4m (FY, 2025) | Gross profit $121m (FY, 2025) |
Net income | Net income ($220.5m) (FY, 2025) | Net income ($38.6m) (FY, 2025) | Net income ($6.1m) (FY, 2025) | Net income $99.7m (FY, 2025) | Net income ($68.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 54m | Total funding raised $ 69.5m | Total funding raised N/A | Total funding raised $ 80.1m | Total funding raised $ 359.4m |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyAssembly Biosciences
HQ
South San Francisco, US
Employees
115↑ 21% increase
Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.
View companyCorcept Therapeutics
HQ
Redwood City, US
Employees
500↑ 42% increase
Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.
View companyInotiv
HQ
West Lafayette, US
Employees
1,945
Inotiv (formerly known as BioAnalytical Systems) is a company that provides research services to pharmaceutical and biotechnology companies.
View company